CoChat

Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Abstract Olanzapine is an effective antipsychotic drug but since it causes significant weight gain, it is not well tolerated by psychosis patients. The prebiotic, B-GOS®, attenuates metabolic dysfunction in obese subjects, and in rodents, alters central NMDA receptors and may affect serotonin receptors that are relevant in psychosis. We have determined whether B-GOS®influenced olanzapine-associated weight gain and central NMDA and serotonin receptors. Circulating acetate, IL-1β, IL-8 and TNFα, liver acetyl-CoA carboxylase (ACC), white adipose tissue (WAT) acetate receptor GPR43, and specific faecal bacteria genera were also measured to provide mechanistic information. Adult female Sprague-Dawley rats were administered a B-GOS®(0.5 g/kg/day) solution or water for 21 days, and received a single, daily, intraperitoneal injection of olanzapine or saline on days 8–21. The intake of B-GOS®significantly attenuated olanzapine-induced weight gain without altering frontal cortex 5-HT2AR blockade. Cortical GluN1 levels were elevated by olanzapine in the presence of B-GOS®. Plasma acetate concentrations increased following B-GOS®or olanzapine administration alone, but reduced when prebiotic and drug were administered in combination. This pattern was paralleled by hepatic ACC mRNA expression. The abundance of WAT GPR43 mRNA was reduced by olanzapine, only in the absence of B-GOS®. Co-administration of B-GOS®and olanzapine also elevated plasma TNFα, which is reported to influence lipid metabolism. Finally, B-GOS®elevated faecalBifidobacteriumspp. and reduced some bacteria in the Firmicutes phylum, whilst olanzapine treatment either alone or with B-GOS®, was without effect. These data suggest that inclusion of B-GOS®as an adjunct to olanzapine treatment in schizophrenia may prevent weight gain and have benefits on cognitive function in psychosis. The role of acetate in these effects requires further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-018-0116-8

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Effect of B-GOS® (0.5 g/kg/day) ingestion and olanzapine (10 mg/kg/day) administration on weight gain in adult female rats. Animals ingested B-GOS® 7 days prior to, and throughout the 2-week administration of olanzapine. a Percentage weight gain was calculated from the day before olanzapine administration. b Area under the curve analysis. Results are expressed as mean ± SEM for each group (n = 6); *p < 0.05, compared to the saline/olanzapine group
Fig. 1 Effect of B-GOS® (0.5 g/kg/day) ingestion and olanzapine (10 mg/kg/day) administration on weight gain in adult female rats. Animals ingested B-GOS® 7 days prior to, and throughout the 2-week administration of olanzapine. a Percentage weight gain was calculated from the day before olanzapine administration. b Area under the curve analysis. Results are expressed as mean ± SEM for each group (n = 6); *p < 0.05, compared to the saline/olanzapine groupCC BY · PubMed Central
Fig. 2 Effect of B-GOS® and olanzapine administration in adult female rats on the cortical protein and gene expression of (a, b) 5-HT2AR, (c, d) GluN1 subunit, and (e, f) GluN2A subunit, respectively. Animals ingested B-GOS® 7 days prior to, and throughout, the 2-week administration of olanzapine. Results are expressed as mean ± SEM for each group (n = 6). *p < 0.05
Fig. 2 Effect of B-GOS® and olanzapine administration in adult female rats on the cortical protein and gene expression of (a, b) 5-HT2AR, (c, d) GluN1 subunit, and (e, f) GluN2A subunit, respectively. Animals ingested B-GOS® 7 days prior to, and throughout, the 2-week administration of olanzapine. Results are expressed as mean ± SEM for each group (n = 6). *p < 0.05CC BY · PubMed Central
Fig. 3 Effect of B-GOS® and olanzapine administration on the faecal bacterial composition in female rats. Animals ingested B-GOS® 7 days prior to, and throughout, the 2-week administration of olanzapine. Results are expressed as fold-change relative to the saline/water group, and presented with medians [first quartile to third quartile]. *p < 0.05, compared to the saline/water group
Fig. 3 Effect of B-GOS® and olanzapine administration on the faecal bacterial composition in female rats. Animals ingested B-GOS® 7 days prior to, and throughout, the 2-week administration of olanzapine. Results are expressed as fold-change relative to the saline/water group, and presented with medians [first quartile to third quartile]. *p < 0.05, compared to the saline/water groupCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 128

Metadata

Authors
Kao, A. C.-C., Spitzer, S., Anthony, D. C., Lennox, B., & Burnet, P. W. J.
Affiliations
University of Oxford (GB)
Corresponding author
Burnet, Philip W. J.
Venue
Translational Psychiatry
Published
2018-03-15
Volume
8
Issue
1
Pages
66-66
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2792991637
Cited by
128
References
64
Citations by year
2026: 9 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 14 · 2021: 17 · 2020: 26 · 2019: 18 · 2018: 9
FWCI
14.48
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (BB/N010035/1)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
olanzapine, weight gain, prebiotics, gut microbiota, NMDA receptor, serotonin receptors, acetate, acetyl-CoA carboxylase, GPR43, white adipose tissue, TNF-α, Bifidobacterium, schizophrenia, antipsychotic adverse effects, GluN1
MeSH terms
Gastrointestinal Microbiome, Olanzapine, Animals, Cerebral Cortex, Feces, Female, Receptors, Serotonin, Antipsychotic Agents, Biomarkers, Weight Gain, Receptors, N-Methyl-D-Aspartate, Rats, Sprague-Dawley, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota. https://app.cochat.ai/papers/10.1038/s41398-018-0116-8
The paper
Kao, A. C.-C., Spitzer, S., Anthony, D. C., Lennox, B., & Burnet, P. W. J. (2018). Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota. Translational Psychiatry. https://doi.org/10.1038/s41398-018-0116-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.